Relationships of lipoprotein (a) with the metabolic syndrome in type 2 diabetes mellitus

被引:0
|
作者
Liu, Yu [1 ]
Shi, Hong-Li [1 ]
Zhu, Xi-Xing [1 ]
机构
[1] Diabetes Research Department, Huashan Hospital, Fudan University, Shanghai 200040, China
来源
Fudan University Journal of Medical Sciences | 2004年 / 31卷 / 01期
关键词
Correlation theory - Insulin - Metabolism - Organic acids - Patient monitoring;
D O I
暂无
中图分类号
学科分类号
摘要
Purpose: To examine the correlation between lipoprotein (a) [LP (a)] and members of metabolic syndrome in type 2 diabetes mellitus(DM). Methods: We utilized cross-sectional study to investigate the level of LP (a) of 1040 patients with type 2 DM in Shanghai, and adopt spearman single-agent and partial correlation to analyze the correlation between LP (a) and metabolic syndrome in type 2 DM, then grouped the subjects according to magnitude of accompanying members of metabolic syndrome, and compared the significance of the level of LP (a) among groups. Results: Level of LP (a) of patients with type 2 DM increased with the accretion of uric acid, urine albumin excretion, fasting glucose, low density lipoprotein, decreased with the promotion of insulin sensitivity. Moreover, the more the magnitude of accompanying members, the higher the level of LP (a). Conclusions: Intimate relationships existed between LP (a) and metabolic syndrome; detection of level of LP (a) of patients with type 2 DM might be conducive to determining the degree of metabolic syndrome. Lowering of LP (a) would benefit to prevent the occurrence of chronic complications of type 2 DM.
引用
收藏
页码:36 / 38
相关论文
共 50 条
  • [1] Lipoprotein distribution in the metabolic syndrome, type 2 diabetes mellitus, and familial combined hyperlipidemia
    Ayyobi, AF
    Brunzell, JD
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (4A): : 27J - 33J
  • [2] METABOLIC SYNDROME IN TYPE 2 DIABETES MELLITUS
    Nakamori, Takako
    Tsushima, Motoo
    ANNALS OF NUTRITION AND METABOLISM, 2009, 55 : 675 - 675
  • [3] Metabolic syndrome and type 2 diabetes mellitus
    Sachse, G
    MEDIZINISCHE WELT, 2000, 51 (7-8): : 198 - 203
  • [4] Metabolic syndrome and diabetes mellitus type 2
    Vukotic, J.
    Milovancevic, S.
    Bunjak, L.
    Grujic, B.
    SWISS MEDICAL WEEKLY, 2009, 139 (33-34) : 86S - 86S
  • [5] Relationships of apolipoprotein B100 with the metabolic syndrome in Type 2 diabetes mellitus
    Relimpio, F
    Losada, F
    Pumar, A
    Mangas, MA
    Morales, F
    Astorga, R
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2002, 57 (03) : 199 - 207
  • [6] Effects of cardiac rehabilitation on lipoprotein abnormalities in patients with Type 2 diabetes mellitus and metabolic syndrome
    Caulin-Glaser, Teresa
    Falko, James M.
    FUTURE LIPIDOLOGY, 2006, 1 (01): : 65 - 73
  • [7] Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus
    Brunzell, JD
    Ayyobi, AF
    AMERICAN JOURNAL OF MEDICINE, 2003, 115 : 24 - 28
  • [8] Glucocorticoids in type 2 diabetes mellitus and the metabolic syndrome
    Welles, Bernice
    DRUG DEVELOPMENT RESEARCH, 2006, 67 (07) : 570 - 573
  • [9] The Predisposition for Type 2 Diabetes Mellitus and Metabolic Syndrome
    Zenoaga-Barbarosie, C.
    Berca, L.
    Vassu-Dimov, T.
    Toma, M.
    Nica, M., I
    Alexiu-Toma, O. A.
    Ciornei, C.
    Albu, A.
    Nica, S.
    Nistor, C.
    Nica, R.
    BALKAN JOURNAL OF MEDICAL GENETICS, 2023, 26 (01) : 21 - 26